Geode Capital Management, LLC Night Hawk Biosciences, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.5 - $0.72 $14,779 - $21,282	-29,559 Reduced 12.26%	211,482 $112,000
Q4 2022 Feb 13, 2023	SELL	$0.77 - $1.62 $501 - $1,054	-651 Reduced 0.27%	241,041 $194,000
Q2 2022 Aug 12, 2022	SELL	$1.65 - $3.13 $12,949 - $24,564	-7,848 Reduced 3.14%	241,692 $616,000
Q1 2022 May 13, 2022	SELL	$2.1 - $3.54 $33,381 - $56,271	-15,896 Reduced 5.99%	249,540 $763,000
Q3 2021 Nov 12, 2021	BUY	$5.9 - $7.44 $283,436 - $357,417	48,040 Added 22.1%	265,436 $1.58 Million
Q2 2021 Aug 13, 2021	BUY	$5.78 - $9.6 $146,193 - $242,812	25,293 Added 13.17%	217,396 $1.46 Million
Q1 2021 May 12, 2021	BUY	$5.67 - $12.54 $325,123 - $719,056	57,341 Added 42.55%	192,103 $1.4 Million
Q4 2020 Feb 12, 2021	BUY	$5.28 - $9.59 $711,543 - $1.29 Million	134,762 New	134,762 $722,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.